Daniel F Hayes Selected Research

Daniel F Hayes Research Topics

Disease

196	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2002
103	Neoplasms (Cancer) 01/2024 - 02/2002
19	Circulating Neoplastic Cells 01/2024 - 03/2005
12	Neoplasm Metastasis (Metastasis) 10/2023 - 08/2003
8	Pain (Aches) 10/2022 - 09/2008
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2018
7	Hot Flashes 11/2015 - 04/2002
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 02/2003
5	Triple Negative Breast Neoplasms 01/2023 - 12/2016
5	Leukemia 08/2011 - 02/2002
3	Carcinoma (Carcinomatosis) 04/2021 - 05/2014
3	Cognitive Dysfunction 10/2020 - 09/2014
3	Pathologic Complete Response 10/2019 - 08/2005
3	Disease Progression 01/2016 - 07/2006
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2010 - 12/2008
3	Colorectal Neoplasms (Colorectal Cancer) 04/2009 - 11/2006
2	Neutropenia 01/2023 - 11/2010
2	Microsatellite Instability 11/2022 - 11/2006
2	Osteonecrosis (Kienbock's Disease) 01/2022 - 01/2020
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 07/2018 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 02/2012
2	Syndrome (Syndromes) 01/2016 - 08/2014
2	Fatigue 09/2014 - 08/2014
2	Chronic Pain 05/2014 - 12/2011
2	Lung Neoplasms (Lung Cancer) 10/2013 - 11/2011
2	Colonic Neoplasms (Colon Cancer) 11/2011 - 11/2006
1	Thrombocytopenia (Thrombopenia) 01/2023

Drug/Important Bio-Agent (IBA)

43	Hormones (Hormone)IBA 10/2022 - 02/2003
37	Estrogen ReceptorsIBA 10/2023 - 03/2003
33	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2004
24	Tumor Biomarkers (Tumor Markers)IBA 01/2024 - 03/2005
22	Tamoxifen FDA LinkGeneric 03/2022 - 02/2002
21	Aromatase InhibitorsIBA 01/2024 - 09/2006
20	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
19	Estrogens (Estrogen)FDA Link 03/2022 - 12/2008
17	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 02/2002
16	Letrozole (Femara)FDA LinkGeneric 10/2022 - 09/2008
16	exemestane (Aromasin)FDA Link 10/2022 - 09/2008
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 02/2002
14	Progesterone Receptors (Progesterone Receptor)IBA 10/2023 - 12/2008
14	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2003
13	human ERBB2 proteinIBA 10/2023 - 01/2007
9	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 04/2006
9	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2013 - 12/2003
7	Circulating Tumor DNAIBA 01/2024 - 10/2017
7	AnthracyclinesIBA 09/2023 - 06/2002
7	ErbB Receptors (EGF Receptor)IBA 11/2022 - 10/2007
7	Fulvestrant (Faslodex)FDA Link 03/2022 - 08/2012
6	Anastrozole (Arimidex)FDA LinkGeneric 01/2022 - 03/2012
6	RNA (Ribonucleic Acid)IBA 04/2021 - 05/2002
6	ParaffinIBA 12/2019 - 08/2011
5	Formaldehyde (Formol)FDA Link 12/2019 - 08/2011
5	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 02/2002
4	taxaneIBA 10/2022 - 12/2011
4	Capecitabine (Xeloda)FDA Link 01/2012 - 07/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 03/2022 - 05/2012
3	AZD9496IBA 03/2022 - 12/2018
3	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2007
3	LigandsIBA 04/2020 - 12/2018
3	Trastuzumab (Herceptin)FDA Link 11/2017 - 12/2008
3	ametantrone (HAQ)IBA 07/2017 - 09/2008
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 02/2003
3	Carcinoembryonic AntigenIBA 08/2015 - 11/2006
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2023
2	Everolimus FDA Link 01/2022 - 01/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 01/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 04/2009
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	B7-H1 AntigenIBA 01/2021 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 07/2003
2	Phosphotransferases (Kinase)IBA 12/2016 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2016 - 12/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 04/2016 - 12/2008
2	LipidsIBA 03/2016 - 12/2012
2	Progesterone FDA LinkGeneric 01/2016 - 05/2015
2	Docetaxel (Taxotere)FDA Link 03/2013 - 07/2007
2	4-hydroxy-N-desmethyltamoxifenIBA 03/2012 - 07/2006
2	Serotonin (5 Hydroxytryptamine)IBA 12/2011 - 04/2002
2	AntibodiesIBA 08/2011 - 06/2009
2	EnzymesIBA 11/2010 - 01/2005
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2008 - 02/2003
2	Cyclin EIBA 11/2007 - 12/2006
2	Thymidine PhosphorylaseIBA 07/2007 - 11/2006
2	Paroxetine (Paxil)FDA LinkGeneric 10/2005 - 12/2003
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2005 - 12/2003

Therapy/Procedure

100	Therapeutics 05/2023 - 04/2002
46	Drug Therapy (Chemotherapy) 01/2024 - 01/2003
23	Adjuvant Chemotherapy 01/2021 - 06/2002
7	Neoadjuvant Therapy 10/2019 - 04/2002
6	Radiotherapy 01/2020 - 04/2002
5	Precision Medicine 01/2023 - 01/2014
4	Lymph Node Excision (Lymph Node Dissection) 10/2007 - 04/2002
3	Aftercare (After-Treatment) 11/2017 - 12/2006
2	Time-to-Treatment 10/2022 - 01/2006
2	Mastectomy (Mammectomy) 05/2015 - 09/2009
2	Chemoprevention 02/2010 - 11/2004
2	Segmental Mastectomy (Lumpectomy) 09/2009 - 04/2002
1	Polypharmacy 01/2024